Needham & Company maintains a 'Buy' on Hi Tech Pharmacal (NASDAQ: HITK), PT lowered from $33 to $25.

Needham analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE